Australia's largest stock trading and investment forum Australia's #1 stock forum

132 deaths in Australia from the trial covid vaccination between 01/01/21 - 02/05/21, page-256

First 256 Last

Share
Profile

Follow
ramAustralia

22,674 Posts.

125

20/08/21

14:59

Post #: 55448356
Share

Originally posted by HCuser7: ↑

First thing you see on the TGA Database of Adverse Event Notifications - medicines is

"An adverse event report does not mean that the medicine is the CAUSE of the adverse event." Like I can say, "Everyone reading this post will die" which will be absolutely true in time, but their death has nothing to do with reading this post.

Your "number of cases where death was a reported outcome: 206" has nothing to do with if a COVID vaccine caused the death. As I keep quoting and you keep ignoring: "Since the beginning of the vaccine rollout to 18 July 2021, over 10.1 million doses of COVID-19 vaccines have been given. The TGA has received and reviewed 399 reports of deaths in people who have recently been vaccinated and found SIX that were linked to immunisation. These deaths were all related to the first dose of the AstraZeneca vaccine – five were TTS cases and one was a case of immune thrombocytopenia (ITP)." TGA 22Jul2021 report

I rest my case.

Expand

If you shoot somebody in the head it doesn't mean the bullet was the cause of death, but see if the police and the judge believe you.
2 Upvote

Reply

Top Stories

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

BRX

Belararox delineates another porphyry in Argentina at Tambo South

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

STX

Strike Energy secures $153 million for Perth Basin gas projects

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

FHE

Frontier Energy achieves key milestone for Waroona energy project

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

EMD

Emyria's Empax Centre chosen for mental health clinical trial

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

There are more pages in this discussion • 13 more messages in this thread...

First 256 Last

SPONSORED BY